Trial Profile
The Study of Efficacy and Safety of Calcium Sensing Receptor in Chronic Dialysis Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Cinacalcet (Primary)
- Indications Hypercalcaemia; Secondary hyperparathyroidism
- Focus Adverse reactions; Therapeutic Use
- 27 Mar 2017 Status changed from recruiting to completed.
- 11 Mar 2014 New trial record